Wed, Oct 22, 2014, 1:01 AM EDT - U.S. Markets open in 8 hrs 29 mins


% | $
Quotes you view appear here for quick access.

Dynavax Technologies Corporation Message Board

bigredkachina 23 posts  |  Last Activity: 11 hours ago Member since: Aug 12, 2005
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Back to 3

    by bigredkachina 11 hours ago
    bigredkachina bigredkachina 11 hours ago Flag

    Oh, forgot to mention insiders buying at 2.26.

  • bigredkachina by bigredkachina 11 hours ago Flag

    Here's the thing. At least every other printer sold globally the next 2 yrs will have NEON Z-force touch interface on it. Amazon is back. Auto is still there. And maybe, just maybe a major break in the PC market pending. Trading at 1.79 5 days ago. Hit 2.70 in premarket today. Nearly 9 million shorts have to cover. Get the picture?

  • Reply to

    Losing Patience

    by yup196 Oct 20, 2014 3:20 PM
    bigredkachina bigredkachina Oct 20, 2014 3:54 PM Flag

    Hurts when they squeeze those nads, eh? Consider there are millions, probably tens of millions of WYY shares bought for below 1.00 Accumulation is a slow process whereby the holders have to be continually frightened off their position. Check back in a year and the same conversation will still be occurring but the pps will be in a different range, certainly north of 2.

  • Reply to

    OTIV needs to update us with news

    by cookinwithgas9 Oct 20, 2014 1:51 PM
    bigredkachina bigredkachina Oct 20, 2014 2:20 PM Flag

    C'mon guys, what you going to do, sell the pop if news? I'm willing to wait until 11/25 for their qtr numbers for news. That's only thing that will really move this. Might have to wait until March to see Apple Pay impact. Hopefully they can beat $7m revenue in Nov. Other than getting huge lock contract for million readers what is there to say?

  • bigredkachina by bigredkachina Oct 9, 2014 5:26 PM Flag

    This reminds me of WYY, another of my holdings. WYY filed a $25 million shelf to ramp up for $600 million BPA they had won from Homeland Security. Shelf was filled at 1.35 when stock was trading at 1.60. This was January of this year. Of course everybody was scam this scam that. Stock fell all the way to 1.25. Stock now at 1.66, been to 2 a couple of times since. In the meantime like here, there were packs of jackals trying to pry shares away from shareholders by claiming pump and dump, fraud, no value to the company, etc. Soon WYY will be a double from 1.35 I expect it will occur less than a year after the shelf, which was in January 2014.

    So, OTIV is filing a shelf for $50 million. Big deal. Ivy still sitting on all his shares. What are they ramping up for? My guess is mass adoption of NFC technologies. Of course I might be wrong. Maybe they don't have any intellectual IP in this area. Maybe revenue didn't really jump $2 million past qtr from previous qtr. Hell, maybe NFC is just a hoax and these Israelis are scamming me for my money like some of the idiots on this board insist. Even so, I like my chances here. NFC is a global phenomenon which is poised for geometric growth. Readers will be needed in all the usual places, banks, vending machines, fuel pumps, etc. and in places you can't even imagine today as the technology becomes mainstream. I expect OTIV might even sell a few of those WAVE's along the way for the gazillion phones out there that are not pre-loaded NFC compliant but whose users want a secure means to conduct NFC transactions. You think?

    Do your own due diligence but don't let a bunch of snarky idiots be part of your equation.

  • bigredkachina by bigredkachina Oct 9, 2014 4:39 PM Flag

    According to the new market research report, now available on ASDReports, "Fingerprint Sensors Market by Type (Swipe And Area), Material (Optical Prism, Pizeoelectric, Capacitive,and Adhesives), Application (Mobile Devices, Government, Defense, Healthcare, Commercial Security and Banking & Finance), and Geography - Global Trends & Forecasts to 2014 - 2020", the global fingerprint sensor market is projected to cross $14.35 Billion by 2020, growing at a high CAGR of 16.8% from 2014 to 2020.

    Today, using biometrics for authentication purpose provides greater convenience and reliability. Fingerprint sensors are the leading biometric technology in consumer electronics, equipped with secured authentication system. In recent times, smartphones, tablets, and PDAs are becoming the most indispensable gadget of our everyday lives. Fingerprint sensors enable fast, secure, and reliable access to smartphone as lots of personal information like contacts, payment details, texts, location data, and mails are stored in some kind of encrypted form on the phone.

    The fingerprint sensors are having wide application not only in mobiles but also in areas such as government, criminal identification, defense, travel and migration, banking and finance, healthcare, smart homes, and commercial security.

    The fingerprint sensor market is segmented into five categories that include materials used, sensor types, biometric types, application, and geography. This report divides the overall market into four main geographical segments, namely North America, Europe, APAC, and ROW. APAC is currently the highest contributor in terms of the market growth as compared to the other regions.

    The leading companies in the fingerprint sensor market covered in the report are AuthenTec Inc. (owned by Apple, Inc.), Synaptics (U.S.), Fingerprint Cards AB (Sweden), IDEX ASA (Norway), Next Biometric (Norway), Atmel Corporation (U.S.), Fujitsu Ltd (Japan), BIO-key International Inc. (U.S.), 3M (U.S.), Infineon Techn

  • Reply to

    Conference call

    by wishmd Oct 8, 2014 1:25 PM
    bigredkachina bigredkachina Oct 9, 2014 11:21 AM Flag

    877-660-6853 13592997# for replay of call.

  • bigredkachina by bigredkachina Oct 7, 2014 10:06 AM Flag

    This is the part of buy low sell high that most don't get. The NFC market is set to boom the next 5 years. These guys are positioned better than most to benefit. Can't wait until Google or NCR or Fujitsu come sniffing around for their reader technology. Just a matter of time. In the meantime, I hope every one of you suckers panic and sell everything you have. I have plenty of dry powder left for this one.

  • bigredkachina by bigredkachina Sep 25, 2014 11:45 AM Flag

    5k @ 2.82-2.84 Will hold until earnings and reevaluate.

  • Reply to

    Back in.

    by bigredkachina Sep 22, 2014 11:16 AM
    bigredkachina bigredkachina Sep 23, 2014 2:26 PM Flag

    Had bought in high 4's and held thru rise and fall from 8. Told myself if it ever got back to 7 I would sell. It got there I sold then the negativity started. Bought a couple more thousand today at 2.16 this morning. Funny, how they rose so high with no products and now that they are putting some out they are crushed. This is way overdone and I see them heading back up in a week or two. The insider buying is a good sign.

  • bigredkachina by bigredkachina Sep 22, 2014 11:16 AM Flag

    Been a long time. Sold way back when it was still in 7's. What a fall. Entry point 2.24 this a.m. I expect it to be back at 3 in near future.

  • bigredkachina by bigredkachina Sep 9, 2014 4:36 PM Flag

    Nearly half my position here stopped out this a.m. Still have 11k shares. Still a believer. Just figured back to 6 was a gift on no news. Building war chest for Alibaba IPO. Been adding YHOO, FB and WYY. Sold EGHT, RFMD and MSLP after decent gains. Will be back here on breaking news or assays start making money.

  • bigredkachina by bigredkachina Sep 5, 2014 1:20 PM Flag

    Thought this would keep pace with my LVLT and INFN but it hasn't come close. Been a good run but might be time to move on if not back to 10 by Christmas.

  • bigredkachina by bigredkachina Sep 5, 2014 1:10 PM Flag

    Seems so to me. Of course I'm tickled it is back at its old stomping grounds at 6.

  • bigredkachina by bigredkachina Aug 28, 2014 3:49 PM Flag

    On May 27 I wrote: "Clock is ticking for short interest. Only peg left is earnings shortfall and that will diminish as earnings from new contracts start hitting the books this fall and beyond. I see 2+ here by Labor Day."

    Well, short interest went down from 3.1m to .6m since I wrote this. Looks like I missed the 2+ by Labor Day here as pps is still sub 1.60 as I write. Hard to figure that with everything this company has going for it.

    However, on a much brighter note, my TROV is killing it for the month of August. A double so far with a $10 target. Win some, lose some.

  • Reply to

    Clock is ticking for short interest

    by bigredkachina May 27, 2014 11:10 AM
    bigredkachina bigredkachina Aug 28, 2014 11:27 AM Flag

    Well, short interest went down from 3.1m to .6m since I wrote this. Looks like I missed the 2+ by Labor Day here as pps is still sub 1.60 as I write. Hard to figure that with everything this company has going for it.

    However, on a much brighter note, my TROV is killing it for the month of August. A double so far with a $10 target. Win some, lose some.

  • Nothing really new on conference call. The next few months will be interesting. I noticed short interest is down to 3.6% from 4.13% but short interest is not what is driving pps.

    A couple of things were clarified for me listening to Trov execs answer the questions from Maxim. Overall Trovagene has to build its case thoroughly on multiple fronts and that there is an abundance of interest across the board in their approach, to the point that they turn down more requests than they service and that those partnerships they participate in are laser focused to service their strategy for the divergent needs their technology addresses.

    Also, they are building an automated system that will service a wide range of genomic queries with one pass. So, no one-off assays are being provided which I think confuses many here who thought the one-offs for KRAS, BRAF, HPV etal. would be generating revenue by now are to be bundled into the automated pass.

    They also seemed to relish the idea that FDA was considering regulating some LDT activity.

    All in all it seems to me that they are still making progress towards commercialization. I get the sense that the cancer clinics' personnel conducting the studies are excited about the concept and promoting from within, even to the point of insisting that it be exported to certain of their colleagues as was the case regarding the migration of the Erdheim Chester BRAF from MD Anderson to Sloan Kettering.

    All that being said, I thing pps will hover above 3 and will be driven by catalysts until concrete deals are consummated and profits begin to appear on the bottom line which I'm guessing 2nd qtr 2015.

  • bigredkachina by bigredkachina Aug 6, 2014 11:00 AM Flag

    Modest profit. Bought in the .08's after the fall from .19 Too many shares, not enough profit from royalties to go around. Good luck.

  • Reply to

    Something's up. 3.51 AH

    by bigredkachina Jul 29, 2014 4:59 PM
    bigredkachina bigredkachina Jul 30, 2014 8:03 AM Flag

    Not to quibble but it was 1650, not 1350. Any break in the recent downward pressure is appreciated, if not significant. My last buy was at 3.15 Been in this one for nearly 2 years, started buying when it was in the 2's. Now have nearly 20k shares cost basis at 3.30. I know. Should have sold when 8+ but thought it would be in the teens by now. With their technology, Affordable Care Act passage, I thought it would be a no-brainer cost cutter for the healthcare/insurance industry. Apparently it is way easy to manipulate with no revenue on the books. Add to that the whole bioscience space has generally been sold off since Feb. and you have what we have here. Here's to better days ahead.

  • bigredkachina by bigredkachina Jul 29, 2014 4:59 PM Flag

    Must be some news lurking somewhere that isn't available to us peons yet.

1.510.00(0.00%)Oct 21 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.